EIB signs €30m financing for Ethris respiratory mRNA products
EIB has signed a €30 million ($33 million) financing agreement with Germany-based Ethris to advance clinical development of its portfolio of...
EIB has signed a €30 million ($33 million) financing agreement with Germany-based Ethris to advance clinical development of its portfolio of...